Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: Bioorg Med Chem. 2016 May 5;24(24):6354–6369. doi: 10.1016/j.bmc.2016.05.003

Table 2.

Antitubercular activity of lead benzimidazoles against drug sensitive and drug resistant strains

Compound (MIC99 μg/mL) M. tuberculois strains
H37Rv NHN382 TN587 W210 NHN20

SB-P3G2 0.63 1.25 1.25 1.25 -
SB-P8B2 0.39 0.31 0.16 0.63 -
SB-P17G-C2 0.06 0.06 0.13 0.06 -
SB-P20G3 0.16 0.16 0.16 0.16 -
SB-P17G-A20 0.16 0.16 0.16 0.16 -
SB-P17G-A33 0.39 0.37 0.31 0.47 0.39
SB-P17G-A38 0.31 0.31 0.31 0.47 0.24
SB-P17G-A42 0.18 0.16 0.24 0.31 0.16